Covance, WuXi Abandon Plans For Joint Drug Testing Facility In China
This article was originally published in The Pink Sheet Daily
Executive Summary
Covance’s $50-million acquisition of Eli Lilly’s Greenfield, Ind., campus likely derailed the proposed partnership.